Metrolina Nephrology Associates, PA

Charlotte, North Carolina 28277

2 studies enrolling now · 11 studies all time

What they study most

Anemia, Arteriovenous Fistula, Arteriovenous Graft, Cardiovascular Risk, Chronic Kidney Disease, Chronic Kidney Disease (CKD), Chronic Kidney Diseases, ESRD, End Stage Kidney Disease, End Stage Renal Disease, Hyperphosphatemia, Inflammation

Studies at this site

• EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) — Recruiting now
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• Trial to Evaluate Reduction in Inflammation in Patients With Advanced Chronic Renal Disease Utilizing Antibody Mediated IL-6 Inhibition — Completed
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Creation of an Arteriovenous Fistula to Facilitate Hemodialysis Access — Completed
• An Efficacy and Safety Study of SRM003 in the Treatment of Subjects Undergoing Placement of an Arteriovenous Graft to Facilitate Hemodialysis Access — Stopped early
• KRX-0502 (Ferric Citrate) in Subjects With NDD-CKD and IDA (The COMPASS Trial) — Completed
• A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis — Completed
• Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa — Completed
• A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialysis — Completed
• A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis — Completed